(Q42538239)

1 November 2017

title

Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors. (English)

1 reference

1 November 2017

Rodgers JD

1

1 reference

1 November 2017

Lam PY

2

1 reference

1 November 2017

Johnson BL

3

1 reference

1 November 2017

Wang H

4

1 reference

1 November 2017

Li R

5

1 reference

1 November 2017

Ru Y

6

1 reference

1 November 2017

Ko SS

7

1 reference

1 November 2017

Seitz SP

8

1 reference

1 November 2017

Trainor GL

9

1 reference

1 November 2017

Anderson PS

10

1 reference

1 November 2017

Klabe RM

11

1 reference

1 November 2017

Bacheler LT

12

1 reference

1 November 2017

Cordova B

13

1 reference

1 November 2017

Garber S

14

1 reference

1 November 2017

Reid C

15

1 reference

1 November 2017

Wright MR

16

1 reference

1 November 2017

Chang CH

17

1 reference

1 November 2017

Erickson-Viitanen S

18

1 reference

1 November 2017

publication date

1 October 1998

1 reference

1 November 2017

published in

Chemistry and Biology

1 reference

1 November 2017

volume

5

1 reference

1 November 2017

issue

10

1 reference

1 November 2017

page(s)

597-608

1 reference

Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity.

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2898%2990117-X

7 January 2021

Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2898%2990117-X

7 January 2021

Cyclic HIV protease inhibitors: synthesis, conformational analysis, P2/P2' structure-activity relationship, and molecular recognition of cyclic ureas

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2898%2990117-X

7 January 2021

Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2898%2990117-X

7 January 2021

Protein binding of propisomide.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2898%2990117-X

7 January 2021

Potent cyclic urea HIV protease inhibitors with 3-aminoindazole P2/P2' groups

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2898%2990117-X

7 January 2021

Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild type and protease inhibitor resistant mutants of HIV

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2898%2990117-X

7 January 2021

Stereoselective Synthesis of HIV-1 Protease Inhibitor, DMP 323

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2898%2990117-X

7 January 2021

Potency and selectivity of inhibition of human immunodeficiency virus protease by a small nonpeptide cyclic urea, DMP 323

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2898%2990117-X

7 January 2021

Limited sequence diversity of the HIV type 1 protease gene from clinical isolates and in vitro susceptibility to HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2898%2990117-X

7 January 2021

Weak Binding of VX-478 to Human Plasma Proteins and Implications for Anti-Human Immunodeficiency Virus Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2898%2990117-X

7 January 2021

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2898%2990117-X

7 January 2021

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2898%2990117-X

7 January 2021

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2898%2990117-X

7 January 2021

Preclinical pharmacokinetics and distribution to tissue of AG1343, an inhibitor of human immunodeficiency virus type 1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2898%2990117-X

7 January 2021

10.1016/S1074-5521(98)90117-X

Identifiers

DOI

1 reference

1 November 2017

1 reference